How have ELDN and PRQR total returns compared?

Over the past 10 years, ELDN delivered -37.18% and PRQR delivered -13.48% annualized total return. Past performance doesn't predict future results.

Eledon Pharmaceuticals, Inc. (ELDN) vs ProQR Therapeutics N.V. (PRQR)

A side-by-side comparison of Eledon Pharmaceuticals, Inc. and ProQR Therapeutics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ELDN

Eledon Pharmaceuticals, Inc.

$190M

$2.46HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

PRQR

ProQR Therapeutics N.V.

$174M

$1.65HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

Total return — ELDN vs PRQR

growth of $100 · dividends reinvested · last 10y

ELDN -99.0% (-36.7%/yr)PRQR -76.5% (-13.5%/yr)PRQR compounded faster over this window

Log scale — wide-divergence pair

ELDN PRQR

ELDN vs PRQR: by the numbers

•ELDN is the larger company ($190M vs $174M market cap).
•Both run net losses; ELDN's is the smaller (0.00% vs -229.20% net margin).

Metrics side by side

Valuation

Metric	ELDN	PRQR
P/S ratio	N/A	8.09
P/B ratio	5.75	1.91

Profitability

Metric	ELDN	PRQR
Gross margin	0.00%	83.01%
Operating margin	0.00%	-275.91%
Net margin	0.00%	-229.20%
ROE	-136.83%	-54.27%
ROIC	-74.02%	-42.61%

Growth (annualized)

Metric	ELDN	PRQR
Revenue CAGR (5Y)	N/A	94.34%
Total return CAGR (5Y)	-15.17%	-26.23%

Frequently asked

How have ELDN and PRQR total returns compared?: Over the past 10 years, ELDN delivered -37.18% and PRQR delivered -13.48% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ELDN analysis Full PRQR analysis Interactive comparison tool

Dig into the metrics

Eledon Pharmaceuticals ROE ProQR Therapeutics ROE Eledon Pharmaceuticals operating margin ProQR Therapeutics operating margin Eledon Pharmaceuticals revenue growth ProQR Therapeutics revenue growth Eledon Pharmaceuticals free cash flow ProQR Therapeutics free cash flow

Eledon Pharmaceuticals & ProQR Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.